UNIPEN Platform Commercial Launch
Delivery device for compounded injectable therapies (e.g., in neuroscience/psychiatry)
CommercialActive
Key Facts
Indication
Delivery device for compounded injectable therapies (e.g., in neuroscience/psychiatry)
Phase
Commercial
Status
Active
Company
About Love Lifesciences
Love Lifesciences is a private, early-stage medical technology company developing the UNIPEN, a platform-agnostic injection device system for the compounding pharmacy market. Founded in 2019 and headquartered in New York, the company aims to bring pharmaceutical-grade device standards to compounded injectables, reducing costs and timelines for pharmacies while improving patient experience. Its strategy leverages a partner network and focuses on regulatory-compliant deployment to capture a niche within the broader neuroscience and psychiatry therapeutic sectors.
View full company profile